Healthcare
Live Price
Offline$13.67
+4.11% today
1Y Change
-48.90%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
QuidelOrtho Corporation (QDEL) is a Healthcare stock with a market cap of $860.00M and listed on NASDAQ. The stock last traded around $13.67 and down 48.9% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -1.9%, EPS growth of +45.4%, a dividend yield of 0.0%. What stands out right now is revenue -1.9%, EPS +45.4%, free cash flow +26.0% with operating margin -33.7% and ROIC -18.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines QDEL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QDEL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
QDEL Max Drawdown
-71.85%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for QDEL and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.7B
-48.0% YoY
FY Net Income
$704.2M
+28.3% YoY
Free Cash Flow
$513.1M
-31.1% YoY
Revenue Growth
-1.9%
EPS Growth
+45.4%
Gross Margin
46.7%
Net Margin
-41.5%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2023 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.7B | 2.8B | 3.0B | 3.3B | 1.7B |
| Gross Profit | 1.3B | 1.3B | 1.5B | 1.9B | 1.3B |
| Operating Income | -919M | -2.0B | 139M | 844M | 906M |
| EBITDA | -488M | -1.5B | 607M | 1.1B | 953M |
| Net Income | -1.1B | -2.1B | -10M | 549M | 704M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2023 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 170M | 98M | 119M | 293M | 803M |
| Total Assets | 5.8B | 6.4B | 8.6B | 8.9B | 2.4B |
| Total Liabilities | 3.8B | 3.4B | 3.6B | 3.9B | 501M |
| Shareholder Equity | 1.9B | 3.0B | 5.0B | 4.9B | 1.9B |
| Total Debt | 2.8B | 2.7B | 2.6B | 2.8B | 139M |
| Net Debt | 2.6B | 2.6B | 2.5B | 2.6B | -664M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
806M
-9.0% YoY
Capital Expenditures
293M
-107.8% YoY
Free Cash Flow
513M
-31.1% YoY
Key ratios
Gross Margin
46.7%
Operating Margin
-33.7%
Net Margin
-41.5%
ROE
-46.4%
Debt / Equity
1.46x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.